Tumoroid‐On‐a‐Plate (ToP): Physiologically Relevant Cancer Model Generation and Therapeutic Screening
Advanced Healthcare Materials · 2025-01 · 14 (1)
DOI: 10.1002/adhm.202402060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 13.11.2024. Verfasst von Amir Seyfoori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, University of Victoria, Victoria, BC, V8P 5C2, Canada. Hauptthemen laut MEDLINE: Glioblastoma, Pancreatic Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation.
Abstract (Originalsprache)
Employing three‐dimensional (3D) in vitro models, including tumor organoids and spheroids, stands pivotal in enhancing cancer therapy. These models bridge the gap between two‐dimensional (2D) cell cultures and complex in vivo environments and offer versatile tools for comprehensive studies into cancer progression, drug responses, and tailored therapies. This study introduces the Tumoroid‐on‐a‐Plate (ToP) device, an innovative ope‐surface microfluidic platform designed to create predictive 3D models of solid tumors. The ToP device combines tumor mass, stromal cells, and extracellular matrix (ECM) components, to closely replicate the microenvironment of glioblastoma (GBM) and pancreatic adenocarcinoma (PDAC). Using the advanced ToP model and testing various GBM ECM compositions such as collagen and Rreelin within the model, we can assess how specific elements affect GBM invasiveness. The ToP in vitro model also enables screening chemotherapeutics such as temozolomide and iron‐chelators in a single and binary treatment setting on the complex ECM‐embedded tumoroids to evaluate their toxicity on GBM and PDAC models viability and apoptosis. Furthermore, co‐culturing PDAC tumoroids with human‐derived fibroblasts reveals the pro‐invasive influence of stromal elements on tumor growth and drug response. This research underscores the value of advanced 3D models like ToP in advancing the understanding of cancer complexity and therapy responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Mechanical Engineering, University of Victoria, Victoria, BC, V8P 5C2, Canada.
- Laboratory for Innovations in Micro Engineering (LiME), Department of Mechanical Engineering, University of Victoria, Victoria, BC, V8P 5C2, Canada.
- Apricell Biotechnology Inc., Victoria, BC, V8P 1T5, Canada.
- Division of Medical Sciences, University of Victoria, Victoria, BC, V8P 5C4, Canada.
- Department of Biology, University of Victoria, Victoria, BC, V8P 5C2, Canada.
- Terasaki Institute for Biomedical Innovation, Los Angeles, CA, 90064, USA.
ORCID-Profile: Hector J Caruncho, Patrick B Walter, Mohsen Akbari
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Canada Foundation for Innovation
Zitieren
APA
Seyfoori, A., Liu, K., Caruncho, H. J., Walter, P. B., & Akbari, M. (2025). Tumoroid‐On‐a‐Plate (ToP): Physiologically Relevant Cancer Model Generation and Therapeutic Screening. Advanced Healthcare Materials, 14(1). https://doi.org/10.1002/adhm.202402060
Vancouver
Seyfoori A, Liu K, Caruncho HJ, Walter PB, Akbari M. Tumoroid‐On‐a‐Plate (ToP): Physiologically Relevant Cancer Model Generation and Therapeutic Screening. Advanced Healthcare Materials. 2025;14(1). doi:10.1002/adhm.202402060
BibTeX
@article{Seyfoori2025,
author = {Seyfoori, Amir and Liu, Kaiwen and Caruncho, Hector J and Walter, Patrick B and Akbari, Mohsen},
title = {Tumoroid‐On‐a‐Plate (ToP): Physiologically Relevant Cancer Model Generation and Therapeutic Screening},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {1},
doi = {10.1002/adhm.202402060}
}
EUVIMED